3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Neoplasms
3
Breast Neoplasms
3
Sarcoma
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Thymus Neoplasms
1
Sex Cord-Gonadal Stromal Tumors
1
Sarcoma, Synovial
1
Prostatic Neoplasms
1
Peritoneal Neoplasms
1
Neoplasms, Germ Cell and Embryonal
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mesothelioma
1
Meningioma
1
Lymphoma, Large B-Cell, Diffuse
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Fatigue
1
Dermatofibrosarcoma
1
Cardiovascular Diseases
1
Carcinoma, Squamous Cell
1
Brain Neoplasms
1
Interventions
Doxorubicin
3
pembrolizumab
2
pazopanib
2
Radiotherapy
2
Radiation
2
Ifosfamide
2
selinexor
1
peposertib
1
liposomal doxorubicin
1
avelumab
1
Specimen Handling
1
Quality of Life
1
Proton Therapy
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Immune Checkpoint Inhibitors
1
Imatinib Mesylate
1
Histamine H2 Antagonists
1
Famotidine
1
Dactinomycin
1
Cyclophosphamide
1
Blood Specimen Collection
1
Biopsy
1
BO-112
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Dermatofibrosarcoma
×
Quality of Life
×
1 year
×
Clear all
NCT07169344
2026-01-28
PROSARC-1
Oslo University Hospital
Phase 2
Recruiting
110 enrolled